Role of TRPV1 Receptors in Osteoarthritic Pain

Vanilloid Receptor TRPV1 in Drug Discovery: Targeting Pain and Other Pathological Disorders

Volumn , Issue , 2010, Pages 175-190

  Joshi, Shailen K ^a   Honore, Prisca ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Role of TRPV1 in joint and bone pain; Role of TRPV1 receptors in osteoarthritic pain; TRPV1 antagonist ABT 102 fully reversing osteoarthritic pain following acute dosing

Indexed keywords

EID: 84889305400     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470588284.ch6     Document Type: Chapter

References (53)

1. Ameye LG and Young MF (2006) Animal models of osteoarthritis: lessons learned while seeking the "Holy Grail." Curr Opin Rheumatol 18: 537 - 547.
2. Baron R, Neff L, Louvard D, and Courtoy PJ (1985) Cell - mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100 - kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101: 2210 - 2222.
3. Barton NJ, McQueen DS, Thomson D, Gauldie SD, Wilson AW, Salter DM, and Chessell IP (2006) Attenuation of experimental arthritis in TRPV1R knockout mice. Exp Mol Pathol 81: 166 - 170.
4. Blair HC, Teitelbaum SL, Ghiselli R, and Gluck S (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245: 855 - 857.
5. Buffington AL, Hanlon CA, and McKeown MJ (2005) Acute and persistent pain modulation of attention - related anterior cingulate fMRI activations. Pain 113: 172 - 184.
6. Carlton SM and Coggeshall RE (2001) Peripheral capsaicin receptors increase in the inflamed rat hindpaw: a possible mechanism for peripheral sensitization. Neurosci Lett 310: 53 - 56.
7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat - activated ion channel in the pain pathway. Nature 389: 816 - 824.
8. Chandran P, Pai M, Blomme EA, Hsieh GC, Decker MW, and Honore P (2009) Pharmacological modulation of movement - evoked pain in a rat model of osteoarthritis. Eur J Pharmacol, 613: 39 - 45.
9. Chen X, Tanner K, and Levine JD (1999) Mechanical sensitization of cutaneous C - fiber nociceptors by prostaglandin E2 in the rat. Neurosci Lett 267: 105 - 108.
10. Cho W and Valtschanoff JG (2004) Vanilloid receptor VR1 - positive primary afferents in mouse model of single joint inflammatory osteoarthritis. 34th Annual Meeting of the Society for Neuroscience, San Diego, CA, October 23 - 27, 2004. Program no. 288 - 15.
11. Combe R, Bramwell S, and Field MJ (2004) The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats? Neurosci Lett 370: 236 - 240.
12. Creamer P, Hunt M, and Dieppe P (1996) Pain mechanisms in osteoarthritis of the knee: effect of intra - articular anesthetic. J Rheumatol 23: 1031 - 1036.
13. Cui M, Honore P, Zhong C, Gauvin D, Mikusa J, Hernandez G, Chandran P, Gomtsyan A, Brown B, Bayburt EK, Marsh K, Bianchi B, McDonald H, Niforatos W, Neelands TR, Moreland RB, Decker MW, Lee CH, Sullivan JP, and Faltynek CR (2006) TRPV1 receptors in the CNS play a key role in broad - spectrum analgesia of TRPV1 antagonists. J Neurosci 26: 9385 - 9393.
14. Dieppe PA and Lohmander LS (2005) Pathogenesis and management of pain in osteoarthritis. Lancet 365: 965 - 973.
15. Di Marzo V, Blumberg PM, and Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12: 372 - 379.
16. Dray A and Read SJ (2007) Arthritis and pain. Future targets to control osteoarthritis pain. Arthritis Res Ther 9: 212.
17. Engler A, Aeschlimann A, Simmen BR, Michel BA, Gay RE, Gay S, and Sprott H (2007) Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis. Biochem Biophys Res Commun 359: 884 - 888.
18. Felson DT (2005) The sources of pain in knee osteoarthritis. Curr Opin Rheumatol 17: 624 - 628.
19. Fernihough J, Gentry C, Bevan S, and Winter J (2005) Regulation of calcitonin gene - related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett 388: 75 - 80.
20. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, and Winter J (2004) Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 112: 83 - 93.
21. Ghilardi JR, Rohrich H, Lindsay TH, Sevcik MA, Schwei MJ, Kubota K, Halvorson KG, Poblete J, Chaplan SR, Dubin AE, Carruthers NI, Swanson D, Kuskowski M, Flores CM, Julius D, and Mantyh PW (2005) Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci 25: 3126 - 3131.
22. Ghosh P and Cheras PA (2001) Vascular mechanisms in osteoarthritis. Best Pract Res Clin Rheumatol 15: 693 - 709.
23. Guo A, Vulchanova L, Wang J, Li X, and Elde R (1999) Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11: 946 - 958.
24. Guzman RE, Evans MG, Bove S, Morenko B, and Kilgore K (2003) Mono - iodoacetate - induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 31: 619 - 624.
25. Honore P, Chandran P, Hernandez G, Gauvin DM, Mikusa JP, Zhong C, Joshi SK, Ghilardi JR, Sevcik MA, Fryer RM, Segreti JA, Banfor PN, Marsh K, Neelands T, Bayburt E, Daanen JF, Gomtsyan A, Lee CH, Kort ME, Reilly RM, Surowy CS, Kym PR, Mantyh PW, Sullivan JP, Jarvis MF, and Faltynek CR (2009) Repeated dosing of ABT - 102, a potent and selective TRPV1 antagonist, enhances TRPV1 - mediated analgesic activity in rodents, but attenuates antagonist - induced hyperthermia. Pain 142: 27 - 35.
26. Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, Gomtsyan A, El Kouhen R, Lee CH, Marsh K, Sullivan JP, Faltynek CR, and Jarvis MF (2005) A - 425619 [1 - isoquinolin - 5 - yl - 3 - (4 - trifluoromethyl - benzyl) - urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J Pharmacol Exp Ther 314: 410 - 421.
27. Hunter DJ and Felson DT (2006) Osteoarthritis. BMJ 332: 639 - 642.
28. Immke DC and Gavva NR (2006) The TRPV1 receptor and nociception. Semin Cell Dev Biol 17: 582 - 591.
29. Keeble J, Russell F, Curtis B, Starr A, Pinter E, and Brain SD (2005) Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. Arthritis Rheum 52: 3248 - 3256.
30. Kelly S and Chapman V (2002) Effects of peripheral nerve injury on functional spinal VR1 receptors. Neuroreport 13: 1147 - 1150.
31. Kidd BL (2006) Osteoarthritis and joint pain. Pain 123: 6 - 9.
32. Kidd BL, Photiou A, and Inglis JJ (2004) The role of inflammatory mediators on nociception and pain in arthritis. Novartis Found Symp 260: 122 - 133; discussion 133 - 8, 277 - 9.
33. Kissin EY, Freitas CF, and Kissin I (2005) The effects of intra - articular resiniferatoxin in experimental knee - joint arthritis. Anesth Analg 101: 1433 - 1439.
34. Kosek E and Ordeberg G (2000) Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 88: 69 - 78.
35. Lanyon P, O ' Reilly S, Jones A, and Doherty M (1998) Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space. Ann Rheum Dis 57: 595 - 601.
36. Mao J, Price DD, and Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62: 259 - 274.
37. McGaraughty S, Chu KL, Bitner RS, Martino B, El Kouhen R, Han P, Nikkel AL, Burgard EC, Faltynek CR, and Jarvis MF (2003) Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM. J Neurophysiol 90: 2702 - 2710.
38. Menendez L, Juarez L, Garcia E, Garcia - Suarez O, Hidalgo A, and Baamonde A (2006) Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett 393: 70 - 73.
39. Mezey E, Toth ZE, Cortright DN, Arzubi MK, Krause JE, Elde R, Guo A, Blumberg PM, and Szallasi A (2000) Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1 - like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 97: 3655 - 3660.
40. Numazaki M and Tominaga M (2004) Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord 3: 479 - 485.
41. Ordeberg G (2004) Characterization of joint pain in human OA. Novartis Found Symp 260: 105 - 115; discussion 115 - 21, 277 - 9.
42. Petit - Zeman S (2004) Characteristics of COX2 inhibitors questioned. Nat Rev Drug Discov 3: 726 - 727.
43. Pingle SC, Matta JA, and Ahern GP (2007) Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp Pharmacol 179: 155 - 171.
44. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, and Walker K (2005) Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 114: 339 - 346.
45. Rigoni M, Trevisani M, Gazzieri D, Nadaletto R, Tognetto M, Creminon C, Davis JB, Campi B, Amadesi S, Geppetti P, and Harrison S (2003) Neurogenic responses mediated by vanilloid receptor - 1 (TRPV1) are blocked by the high affinity antagonist, iodo - resiniferatoxin. Br J Pharmacol 138: 977 - 985.
46. Roberts JC, Davis JB, and Benham CD (2004) [3H]Resiniferatoxin autoradiography in the CNS of wild - type and TRPV1 null mice defines TRPV1 (VR - 1) protein distribution. Brain Res 995: 176 - 183.
47. Schaible HG (2004) Spinal mechanisms contributing to joint pain. Novartis Found Symp 260: 4 - 22; discussion 22 - 7, 100 - 4, 277 - 9.
48. Schaible HG and Grubb BD (1993) Afferent and spinal mechanisms of joint pain. Pain 55: 5 - 54.
49. Szallasi A, Cortright DN, Blum CA, and Eid SR (2007) The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof - of - concept. Nat Rev Drug Discov 6: 357 - 372.
50. Valtschanoff JG, Rustioni A, Guo A, and Hwang SJ (2001) Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. J Comp Neurol 436: 225 - 235.
51. Wahl P, Foged C, Tullin S, and Thomsen C (2001) Iodo - resiniferatoxin, a new potent vanilloid receptor antagonist. Mol Pharmacol 59: 9 - 15.
52. Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, and McIntyre P (2003) The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 304: 56 - 62.
53. Wieland HA, Michaelis M, Kirschbaum BJ, and Rudolphi KA (2005) Osteoarthritis - an untreatable disease? Nat Rev Drug Discov 4: 331 - 344.